Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Four patients with a type of rickets and hair loss had different mutations in their vitamin D receptor gene, causing it to not work properly.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

New compounds may soon be tested to treat excessive hair growth in women.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Adrenal disorders often cause high blood pressure in young people.

Excess androgens may cause PCOS, not just be a symptom.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.